Work

Q&A with Karin de Visser

Year: 2025

Type: article

Abstract: Karin de Visser is senior group leader at the Division of Tumor Biology & Immunology at the Netherlands Cancer Institute. In this interview with Cell Reports Medicine, Karin de Visser talks about her journey in science and shares her insights about tumor microenvironment modulation to improve patient therapies.

Source: Cell Reports Medicine

DOI: 10.1016/j.xcrm.2025.102457

Author: Karin de Visser

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,620

Funder: AstraZeneca